| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |